Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04638010 · ClinicalTrials.gov registry record · NA

Increasing Breast, Cervical, and Colorectal Cancer Screening and HPV Vaccination Among Underserved Texans

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
1,554
Enrollment target

NCT04638010: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT04638010 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,554 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04638010, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
1,554 participants
Enrollment target

Study Summary

This study involves a partnership between UTHealth School of Public Health and the Texas 2-1-1 service, which is a helpline connecting low-income and minority callers with a number of needed services. The purpose of this study is to evaluate the effectiveness of a prevention program in which a phone navigator intervention designed to connect 2-1-1 helpline callers to evidence-based screening and prevention services including mammography, Pap test screening, colorectal cancer screening, and HPV vaccination.

Primary Outcome

Cancer screening and prevention services include mammogram, Pap test, HPV vaccine, and/or colorectal cancer screening.

Interventions

  • BEHAVIORAL Cancer control navigation (CNN)
  • BEHAVIORAL General referral (usual care)

Trial Details

FieldValue
Enrollment Target 1,554 participants
Start Date 2011-02-16
Est. Completion 2013-12-06
Phase NA

What the finished NCT04638010 record still lists

NCT04638010 is an interventional study that assigns participants to a tested intervention. Its 1,554 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% higher).

The record links to 0 conditions, and to 2 interventions - of which Cancer control navigation (CNN) is the first listed.

NCT04638010 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04638010 about?

NCT04638010 is a clinical study titled "Increasing Breast, Cervical, and Colorectal Cancer Screening and HPV Vaccination Among Underserved Texans". This study involves a partnership between UTHealth School of Public Health and the Texas 2-1-1 service, which is a helpline connecting low-income and minority callers with a number of needed services. The purpose of this study is to evaluate the effectiveness of a prevention program in which a phone...

What is the current status of trial NCT04638010?

This trial is currently completed. It is a NA study. The enrollment target is 1,554 participants. The study started on 2011-02-16. Estimated completion is 2013-12-06.

What interventions are being tested in trial NCT04638010?

The interventions under investigation include: Cancer control navigation (CNN) (BEHAVIORAL), General referral (usual care) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04638010?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04638010's enrollment target sits among peer trials

1,554 64th of 2000 higher than 1,937 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02650622 · 1,550 participants

    Genetic and Metabolic Disease in Children

  • NCT03961945 · 1,550 participants · NA

    Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

  • NCT06881069 · 1,560 participants · NA

    Reach Through Equitable Implementation in Utah

  • NCT06729775 · 1,546 participants · NA

    Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04638010, the US trial registry maintained by the National Library of Medicine. NCT04638010 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.